Navigation Links
BioSpec Global Solutions Inc. Enters into talks with possible Chinese partner
Date:7/21/2010

NEW YORK and MONTREAL, July 21 /PRNewswire-FirstCall/ - BioSpec Global Solutions Inc., and partner -ICBS Ltd. (OTCPK: ICBT), announced today that the company has entered into talks with a new possible Chinese partner.

"China is one of the world's largest markets for our analyzer's and has one of the worst water situations on the planet" said Don Saunders President and CEO of BioSpec Global Solutions. We have made contact with a new possible Chinese partner. The unnamed party has entered into preliminary talks with BGS that would see BGS make a quicker entry into the lucrative Chinese market.

The company is in production of the TOG's 3000 which will lead the market development in China. However should the company sign with the unnamed partner the company could see manufacturing shift to China. BioSpec Global Solutions, has developed the TOGS 3000 to analyze total bacterial count in water samples. Given the advantages not only on time advantage (24 Hours for test results) but the accuracy of these machines, can equip agencies with the technology needed to insure safe drinking water for their citizens.

BioSpec Global Solutions Inc., has a non-exclusive agreement with Beijing Titan Instruments co.

Verification studies for the TOGS(TM) 9000 has been completed by Ryerson University and the instrument has, like the Pro3000(TM), been accepted by the EPA in the USA for use in presence absence testing of drinking water when used with an EPA approved method and reagent. The TOGS(TM)9000 has been used by the United Nation for a emergency relief project in the Dominican Republic. A verification study by Michigan State University, an EPA laboratory, is ongoing for viruses. Further verification and validation studies will be done shortly by users and ETV (Environmental Technology Verification) for microbial quantification for beach and wastewater applications.

The company holds worldwide patents on the TOGS 3000 and 9000.

NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.


'/>"/>
SOURCE BioSpec Global Solutions Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpec Global Solutions Inc, takes delivery of new TOGs 3000 Home edition for the U.S. and international markets
2. BioSpec Global Solutions Inc. target market TOGS 9000 to state and municipal regulatory bodies in U.S. market
3. BioSpec Global Solutions Inc., contracts with RMF Design & Manufacturing Inc., for production of the TOGs 3000 and 9000 units for U.S. market
4. Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
5. BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
6. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009
7. BioSpecifics Technologies Corp. Stock Trading Halted Today
8. BioSpecifics Technologies Corp. To Present at BioCentury NewsMakers in the Biotech Industry Conference
9. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
10. BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
11. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):